Check Cap Stock

Check Cap FCF Growth

The Year-over-Year Free Cash Flow Growth of Check Cap (MBAI) as of Aug 11, 2026 is 99.43 %. In the previous year, Year-over-Year Free Cash Flow Growth was 53.02 % — a change of 87.52% (higher).

FCF Growth

99.43 %

YoY

87.52%

Last updated:

Year-over-Year Free Cash Flow Growth of Check Cap is 2026 99.43 % . Year-over-Year Free Cash Flow Growth of Check Cap was 2025 53.02 % . It decreases by 87.52% higher compared to the previous year.
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

Year-over-Year Free Cash Flow Growth of Check Cap is 99.43 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Check Cap since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Check Cap historically and in real time.

Access this data via the Eulerpool API

Growth — Check Cap

All Key Metrics — Check Cap